Andrew H. Lane's most recent trade in Abbott Laboratories was a trade of 10,000 Common shares without par value done at an average price of $130.0 . Disclosure was reported to the exchange on Nov. 15, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Abbott | Andrew H. Lane | EXECUTIVE VICE PRESIDENT | Sale of securities on an exchange or to another person at price $ 130.01 per share. | 15 Nov 2021 | 10,000 | 76,087 (0%) | 0% | 130.0 | 1,300,090 | Common shares without par value |
| Abbott | Andrew H. Lane | EXECUTIVE VICE PRESIDENT | Sale of securities on an exchange or to another person at price $ 125.47 per share. | 27 Aug 2021 | 135,925 | 86,087 (0%) | 0% | 125.5 | 17,055,189 | Common shares without par value |
| Abbott | Andrew H. Lane | EXECUTIVE VICE PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2021 | 135,925 | 0 | - | - | Option (right to buy) | |
| Abbott | Andrew H. Lane | EXECUTIVE VICE PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.40 per share. | 27 Aug 2021 | 135,925 | 222,012 (0%) | 0% | 38.4 | 5,219,520 | Common shares without par value |